By William Hyman – Many initiatives, especially ones that are made mandatory, follow a similar pattern of hype. In our arena we see this in the adoption of EMRs. the establishment of HIEs, and the incorporation of AI.
Read More
By Kayla Matthews – Options for treating patients and helping them stay healthy are rapidly evolving, and improved technology is largely responsible for making that the case. Some of the available offerings could forever change how patients and physicians interact with each other.
By Anshu Jindal – Holiday times are over. 2018 is here and it brings a flurry of activity with it. It is time for 2017 MIPS data submissions, and start off the second year of MIPS on the right foot.
By David Harlow – The FDA had a digital health banner day on December 7, announcing one final guidance and two draft guidance documents (with a 60-day comment period). Collectively, these guidances cover a range of digital health issues.
By Matt Ferrari – In episode three of my HealthcareNOW Radio show, “CTO Talk” I have the pleasure of sharing some time with Scott Maurice, the co-founder and managing partner of Avail Partners.
By Jim Tate – Over the holidays I have been thinking a lot about the MACRA & MIPS program. Maybe too much. Something about it doesn’t sit right with me. I have had a nagging sense that there was a flaw in the program.
By William Hersh MD – As longtime readers of this blog know, I always end each year with an annual reflection on the year past. I did this in the first year of the blog of 2009, and have done it every year since.
By Scott Gottlieb MD & Jeffrey Shuren, MD JD – Recently, the Food and Drug Administration has committed to several new policies that will modernize the agency’s approach to regulation in the medical device system.
The New Year is a time to look back and reflect on the previous year and take into account all that has changed in healthcare and technology in the last 365 days. Wondering what 2018 has in store? Take a look at some of these predictions made by a various companies, analysts and research firms.